CSPC, Alphamab Oncology make an ADC deal; Visen’s IPO in Hong Kong
Plus, news about Sequentia Biotech:
CSPC, Alphamab Oncology ink ADC deal: CSPC Pharmaceutical’s JMT-Bio Technology said it will pay RMB 400 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
